Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Chubb
Julphar
Colorcon
Accenture
Moodys
Federal Trade Commission
Argus Health
McKinsey

Generated: July 17, 2018

DrugPatentWatch Database Preview

Levallorphan tartrate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for levallorphan tartrate and what is the scope of levallorphan tartrate patent protection?

Levallorphan tartrate
is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for levallorphan tartrate
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 10
Patent Applications: 102
DailyMed Link:levallorphan tartrate at DailyMed
Medical Subject Heading (MeSH) Categories for levallorphan tartrate
Synonyms for levallorphan tartrate
(1R,9R,10R)-17-(PROP-2-EN-1-YL)-17-AZATETRACYCLO[7.5.3.0(1),(1)?.0(2),?]HEPTADECA-2,4,6-TRIEN-4-OL; (2R,3R)-2,3-DIHYDROXYBUTANEDIOIC ACID
17-(2-Propenyl)-morphinan-3-ol (2R,3R)-2,3-dihydroxybutanedioate (salt)
17-(2-Propenyl)morphinan-3-ol tartrate
17-Allylmorphinan-3-ol tartrate (1:1) (salt)
2H-10,4a-Iminoethanophenanthren-6-ol, 11-allyl-1,3,4,9,10,10a-hexahydro-, tartrate
71-82-9
C19H25NO.C4H6O6
CCG-222075
CHEMBL1598018
CHEMBL2062276
CTK8G0554
D02238
EINECS 200-767-3
EU-0100771
HMS3262K04
L-121
l-Levallorphan tartrate
Levallorphan (+)-tartrate salt
Levallorphan hydrogen tartrate
Levallorphan tartrate (JP17)
Levallorphan tartrate [JAN]
Levallorphan tartrate [USP:JAN]
Levallorphan tartrate salt
Levallorphan tartrate salt, >=98% (HPLC), powder
Lopac0_000771
LP00771
LS-91867
Morphinan-3-ol, 17-(2-propenyl)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
Morphinan-3-ol, 17-allyl-, tartrate (1:1) (salt)
NALOXIPHANE TARTRATE
NCGC00094110-01
NCGC00261456-01
PL008786
SCHEMBL14973577
SCHEMBL209270
SR-01000076234
SR-01000076234-1
Tartrate de levallorphane
Tartrate de levallorphane [French]
Tox21_500771
U0VSF7HTN0
UNII-U0VSF7HTN0

US Patents and Regulatory Information for levallorphan tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche LORFAN levallorphan tartrate INJECTABLE;INJECTION 010423-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKinsey
Covington
Dow
Express Scripts
Federal Trade Commission
Merck
US Department of Justice
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.